WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹338 Cr | ₹298 Cr | ₹347 Cr | ₹284 Cr | ₹275 Cr |
What is the latest Total Liabilities ratio of WANBURY ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹338 Cr |
Mar2023 | ₹298 Cr |
Mar2022 | ₹347 Cr |
Mar2021 | ₹284 Cr |
Mar2020 | ₹275 Cr |
How is Total Liabilities of WANBURY Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹338 Cr | 13.41 | |
Mar2023 | ₹298 Cr | -14.09 | |
Mar2022 | ₹347 Cr | 22.35 | |
Mar2021 | ₹284 Cr | 2.98 | |
Mar2020 | ₹275 Cr | - |
Compare Total Liabilities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹872.7 Cr | -1.1% | -10.8% | -9.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹392,567.0 Cr | 0.5% | 4.6% | -18.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹151,601.0 Cr | -3.2% | -6.7% | 4.4% | Stock Analytics | |
CIPLA | ₹122,284.0 Cr | 0.3% | -3.5% | -10.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,593.0 Cr | 0.9% | -0.6% | 3.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,014.0 Cr | -2.2% | -0.9% | -9.4% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -1.1% |
-10.8% |
-9.7% |
SENSEX | -0.9% |
0.8% |
-5.7% |
You may also like the below Video Courses